Aspirin-induced Bcl-2 translocation and its phosphorylation in the nucleus trigger apoptosis in breast cancer cells.
Aspirin-induced Bcl-2 translocation and its phosphorylation in the nucleus trigger apoptosis in breast cancer cells.
Exp Mol Med. 2013;45:e47
Authors: Choi BH, Chakraborty G, Baek K, Yoon HS
Abstract
Here, we report that B-cell lymphoma 2 (Bcl-2) is a novel target molecule of aspirin in breast cancer cells. Aspirin influenced the formation of a complex by Bcl-2 and FKBP38 and induced the nuclear translocation of Bcl-2 and its phosphorylation. These events inhibited cancer cell proliferation and subsequently enhanced MCF-7 breast cancer cell apoptosis. Bcl-2 knockdown using small interfering RNA (siRNA) delayed apoptotic cell death, which correlated with increased proliferation following aspirin exposure. In contrast, Bcl-2 overexpression enhanced the onset of aspirin-induced apoptosis, which was also associated with a significant increase in Bcl-2 phosphorylation in the nucleus. Therefore, this study may provide novel insight into the molecular mechanism of aspirin, particularly its anticancer effects in Bcl-2- and estrogen receptor-positive breast cancer cells.
PMID: 24113271 [PubMed - as supplied by publisher]
Source: exp Mol Med - Category: Molecular Biology Authors: Choi BH, Chakraborty G, Baek K, Yoon HS Tags: Exp Mol Med Source Type: research
More News: Aspirin | Breast Cancer | Cancer | Cancer & Oncology | Lymphoma | Molecular Biology | Study | Translocation